Trial Profile
Raltegravir/Atazanavir pharmacokinetics and evaluation of lipids.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 02 Apr 2012
Price :
$35
*
At a glance
- Drugs Atazanavir (Primary) ; Raltegravir (Primary)
- Indications HIV infections
- Focus Pharmacodynamics; Pharmacokinetics
- Acronyms RAPHAEL
- 27 Jul 2011 New trial record